Structured Product Labeling: Ensuring FDA Compliance with fda labeling services
- Alok Naik, MS- Regulatory Affairs
- 2 days ago
- 4 min read
When you plan to export cosmetics, OTC drugs, pharmaceuticals, or food products to the United States, understanding FDA labeling requirements is critical. One of the most important aspects of compliance is Structured Product Labeling (SPL). This system ensures that your product information is submitted in a standardized, machine-readable format that the FDA can efficiently review and process. Navigating SPL requirements can be complex, but with the right knowledge and support, you can avoid costly delays and regulatory issues.
Understanding fda labeling services and Structured Product Labeling
The FDA mandates that product labels for drugs, biologics, and certain other regulated products be submitted electronically using Structured Product Labeling. SPL is an XML-based standard developed by the Health Level Seven International (HL7) organization. It allows the FDA to capture detailed product information such as ingredients, dosage, warnings, and usage instructions in a consistent format.
The key regulation governing SPL is found in 21 CFR Part 314.70 for drugs and 21 CFR Part 601.12 for biologics. These regulations require that all labeling submissions be in SPL format to facilitate review and public dissemination.
For you, this means:
Preparing your product labeling content in compliance with FDA SPL standards.
Submitting the SPL files through the FDA’s Electronic Submissions Gateway (ESG).
Ensuring that your labeling is accurate, complete, and updated as needed.
Failing to comply with SPL requirements can result in delays in product approval, import holds, or even enforcement actions.
Key steps to ensure FDA compliance with your product labeling
To meet FDA requirements, you must follow a clear process when preparing and submitting your product labels:
Understand the SPL format and content requirements
SPL files must include specific sections such as product description, dosage, warnings, and manufacturer information. The FDA provides detailed guidance documents and SPL implementation guides that you should review carefully.
Develop or update your labeling content
Your label text must comply with FDA regulations on content, format, and language. For example, OTC drug labels must follow the 21 CFR Part 201 labeling requirements, including active ingredients, uses, warnings, and directions.
Convert your label content into SPL XML format
This step requires technical expertise. You can use specialized software tools or work with experienced regulatory consultants who offer structured product labeling services to ensure your SPL files are correctly formatted.
Validate your SPL files
The FDA provides validation tools to check your SPL files for errors before submission. Validation helps prevent rejection or delays.
Submit your SPL files via the FDA Electronic Submissions Gateway (ESG)
The ESG is the FDA’s secure portal for receiving electronic submissions. You must register and obtain the necessary credentials to submit your SPL files.
Maintain and update your labeling as required
If you make changes to your product or labeling, you must submit updated SPL files promptly to remain compliant.
By following these steps, you can streamline your FDA labeling process and reduce the risk of non-compliance.
Common challenges and how to overcome them
Many companies face hurdles when implementing SPL requirements, especially if they are new to the U.S. regulatory environment. Some common challenges include:
Technical complexity of SPL XML formatting
SPL files require precise XML coding. Errors in tags, missing sections, or incorrect data can cause submission rejections. To avoid this, consider partnering with experts who specialize in SPL formatting.
Keeping up with FDA updates and guidance
The FDA periodically updates SPL standards and labeling regulations. Staying current is essential to avoid compliance gaps.
Language and content accuracy
Labels must be clear, truthful, and not misleading. For foreign companies, translating and adapting label content to meet FDA expectations can be challenging.
Timely submission and updates
Delays in submitting SPL files or updating labels after product changes can lead to regulatory actions.
To address these challenges, you should:
Invest in training or hire regulatory professionals familiar with FDA labeling rules.
Use reliable software tools or services for SPL file creation and validation.
Establish internal processes for regular label review and updates.
Work with a legally designated U.S. Agent who can assist with FDA communications and submissions.
Why you need a U.S. Agent and FDA facility registration
If you are a foreign manufacturer exporting to the U.S., the FDA requires you to have a legally designated U.S. Agent. This agent acts as your official contact for FDA communications and helps ensure your facility registration and labeling submissions are handled properly.
Facility registration is mandatory under 21 CFR Part 807 for medical devices and 21 CFR Part 207 for food facilities. For drugs and cosmetics, registration and listing requirements vary but are equally important.
Your U.S. Agent will:
Receive FDA correspondence on your behalf.
Assist with facility registration and drug listing.
Help coordinate SPL submissions and labeling compliance.
Provide guidance on FDA inspections and audits.
Without a U.S. Agent and proper facility registration, your products may face import refusals or delays.
Best practices for ongoing FDA labeling compliance
Maintaining compliance is an ongoing effort. Here are practical recommendations to keep your labeling in line with FDA expectations:
Regularly review FDA guidance documents
The FDA website and Federal Register publish updates on labeling requirements and SPL standards.
Implement a labeling change management system
Track all label revisions, approvals, and submission dates to ensure timely updates.
Conduct internal audits of labeling content and SPL files
Periodic reviews help catch errors before FDA inspections or submissions.
Train your regulatory and quality teams
Ensure everyone involved understands SPL requirements and FDA labeling rules.
Outsourcing complex SPL tasks can save time and reduce errors.
By adopting these best practices, you can protect your market access and build trust with U.S. regulators.
Preparing for FDA inspections and label reviews
FDA inspections may include a review of your labeling practices and SPL submissions. To be inspection-ready:
Keep all labeling documentation organized and accessible.
Maintain records of SPL submissions and FDA correspondence.
Demonstrate that your labeling complies with applicable regulations.
Show evidence of timely updates and corrections.
Ensure your U.S. Agent is responsive and informed.
Being proactive in your labeling compliance will help you avoid enforcement actions and maintain smooth operations in the U.S. market.
By understanding and implementing Structured Product Labeling requirements, you position your products for successful entry and sustained compliance in the U.S. market. Taking the right steps now will save you time, reduce risks, and support your business growth.
Comments